Pfizer (PFE) Announces Presentation of Additional XELJANZ Data at 2016 ACR/ARHP Annual Meeting
Tweet Send to a Friend
Pfizer Inc. (NYSE: PFE) announced that 20 abstracts for XELJANZ (tofacitinib citrate) will be presented at the upcoming 2016 ACR/ARHP ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
